Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY

34:19
 
Share
 

Manage episode 455979822 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchEXPERT OPINIONS for touchONCOLOGY

Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.

The experts

  • Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
  • Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  • Dr Teresa Amaral, Tübingen University, Tübingen, Germany

This touchPODCAST is for healthcare professionals outside of the UK only

This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website:
https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 455979822 series 3389426
Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

touchEXPERT OPINIONS for touchONCOLOGY

Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.

The experts

  • Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
  • Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  • Dr Teresa Amaral, Tübingen University, Tübingen, Germany

This touchPODCAST is for healthcare professionals outside of the UK only

This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website:
https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play